Fluorinated carbohydrates for 18F-positron emission tomography (PET)

被引：20
作者：
Campbell, Emma [1 ,2 ]
Jordan, Christina [1 ,2 ]
Gilmour, Ryan [1 ,2 ]
机构：
[1] Westfal Wilhelms Univ Munster, Organ Chem Inst, Corrensstr 36, D-48149 Munster, Germany
[2] Westfal Wilhelms Univ Munster, Cells Mot Interfac Ctr, Rontgenstr 16, D-48149 Munster, Germany
来源：
CHEMICAL SOCIETY REVIEWS | 2023年 / 52卷 / 11期
基金：
欧洲研究理事会;
关键词：
C-F-18 BOND FORMATION; NECK-CANCER PATIENTS; IN-VIVO EVALUATION; ESCHERICHIA-COLI; F-18-LABELED; 2-DEOXY-2-FLUORO-D-GLUCOSE; FLUOROMETABOLITE BIOSYNTHESIS; STRUCTURAL REQUIREMENTS; STREPTOMYCES-CATTLEYA; SUBSTRATE-SPECIFICITY; BIOLOGICAL EVALUATION;
D O I：
10.1039/d3cs00037k
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
Carbohydrate diversity is foundational in the molecular literacy that regulates cellular function and communication. Consequently, delineating and leveraging this structure-function interplay continues to be a core research objective in the development of candidates for biomedical diagnostics. A totemic example is the ubiquity of 2-deoxy-2-[F-18]-fluoro-d-glucose (2-[F-18]-FDG) as a radiotracer for positron emission tomography (PET), in which metabolic trapping is harnessed. Building on this clinical success, more complex sugars with unique selectivities are gaining momentum in molecular recognition and personalised medicine: this reflects the opportunities that carbohydrate-specific targeting affords in a broader sense. In this Tutorial Review, key milestones in the development of 2-[F-18]-FDG and related glycan-based radiotracers for PET are described, with their diagnostic functions, to assist in navigating this rapidly expanding field of interdisciplinary research.
引用
收藏
页码：3599 / 3626
页数：29
相关论文
共 209 条
[1]   STUDIES ON F-18-LABELED PYRIMIDINES - TUMOR UPTAKES OF 5-FLUOROURACIL-F-18, 5-FLUOROURIDINE-F-18, AND 5-FLUORODEOXYURIDINE-F-18 IN ANIMALS [J].
ABE, Y ;
FUKUDA, H ;
ISHIWATA, K ;
YOSHIOKA, S ;
YAMADA, K ;
ENDO, S ;
KUBOTA, K ;
SATO, T ;
MATSUZAWA, T ;
TAKAHASHI, T ;
IDO, T .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1983, 8 (06) :258-261
[2]  
Adam MJ, 1999, J LABELLED COMPD RAD, V42, P809
[3]   A RAPID, STEREOSELECTIVE, HIGH YIELDING SYNTHESIS OF 2-DEOXY-2-FLUORO-D-HEXOPYRANOSES - REACTION OF GLYCALS WITH ACETYL HYPOFLUORITE [J].
ADAM, MJ .
JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1982, (13) :730-731
[4]   l-fucose, a sugary regulator of antitumor immunity and immunotherapies [J].
Adhikari, Emma ;
Liu, Qian ;
Burton, Chase ;
Mockabee-Macias, Andrea ;
Lester, Daniel K. ;
Lau, Eric .
MOLECULAR CARCINOGENESIS, 2022, 61 (05) :439-453
[5]   Closing the gap between 19F and 18F chemistry [J].
Ajenjo, Javier ;
Destro, Gianluca ;
Cornelissen, Bart ;
Gouverneur, Veronique .
EJNMMI RADIOPHARMACY AND CHEMISTRY, 2021, 6 (01)
[6]   In vivo evaluation of 2′-deoxy-2′-[18F]fluoro-5-iodo-1-β-D-arabinofuranosyluracil ([18F]FIAU) and 2′-deoxy-2′-[18F]fluoro-5-ethyl-1-β-D-arabinofuranosyluracil ([18F]FEAU) as markers for suicide gene expression [J].
Alauddin, Mian M. ;
Shahinian, Antranic ;
Park, Ryan ;
Tohme, Michel ;
Fissekis, John D. ;
Conti, Peter S. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (06) :822-829
[7]   Biodistribution and PET imaging of [18F]-fluoroadenosine derivatives [J].
Alauddin, Mian M. ;
Shahinian, Antranik ;
Park, Ryan ;
Tohme, Michael ;
Fissekis, John D. ;
Conti, Peter S. .
NUCLEAR MEDICINE AND BIOLOGY, 2007, 34 (03) :267-272
[8]  
Alauddin MM, 2004, J NUCL MED, V45, P2063
[9]   Synthesis of 2′-deoxy-2′-[18F]fluoro-5-bromo-1-β-D-arabinofuranosyluracil ([18F]-FBAU) and 2′-deoxy-2′-[18F]fluoro-5-chloro-1-β-D-arabinofuranosyl-uracil ([18F]-FCAU), and their biological evaluation as markers for gene expression [J].
Alauddin, MM ;
Shahinian, A ;
Park, R ;
Tohme, M ;
Fissekis, JD ;
Conti, PS .
NUCLEAR MEDICINE AND BIOLOGY, 2004, 31 (04) :399-405
[10]   Evaluation of 9-[(3-18F-fluoro-1-hydroxy-2-propoxy)methyl]guanine ([18F]-FHPG) in vitro and in vivo as a probe for PET imaging of gene incorporation and expression in tumors [J].
Alauddin, MM ;
Shahinian, A ;
Kundu, RK ;
Gordon, EM ;
Conti, PS .
NUCLEAR MEDICINE AND BIOLOGY, 1999, 26 (04) :371-376
12345678910